{"id":27539,"date":"2023-03-23T13:27:37","date_gmt":"2023-03-23T12:27:37","guid":{"rendered":"https:\/\/www.idisantiago.es\/?post_type=project&#038;p=27539"},"modified":"2026-04-24T09:05:23","modified_gmt":"2026-04-24T07:05:23","slug":"e041-epixenomica-en-endocrinoloxia-e-nutricion","status":"publish","type":"project","link":"https:\/\/www.idisantiago.es\/gl\/grupo-de-investigacion\/e041-epixenomica-en-endocrinoloxia-e-nutricion\/","title":{"rendered":"E057 &#8211; Endocrinolox\u00eda translacional"},"content":{"rendered":"<p>[et_pb_section fb_built=&#8221;1&#8243; _builder_version=&#8221;4.16&#8243; _module_preset=&#8221;default&#8221; custom_padding=&#8221;0px||||false|false&#8221; da_disable_devices=&#8221;off|off|off&#8221; global_colors_info=&#8221;{}&#8221; da_is_popup=&#8221;off&#8221; da_exit_intent=&#8221;off&#8221; da_has_close=&#8221;on&#8221; da_alt_close=&#8221;off&#8221; da_dark_close=&#8221;off&#8221; da_not_modal=&#8221;on&#8221; da_is_singular=&#8221;off&#8221; da_with_loader=&#8221;off&#8221; da_has_shadow=&#8221;on&#8221;][et_pb_row _builder_version=&#8221;4.16&#8243; _module_preset=&#8221;default&#8221; width=&#8221;100%&#8221; custom_padding=&#8221;0px||||false|false&#8221; locked=&#8221;off&#8221; collapsed=&#8221;off&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_column type=&#8221;4_4&#8243; _builder_version=&#8221;4.16&#8243; _module_preset=&#8221;default&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_text _builder_version=&#8221;4.16&#8243; _module_preset=&#8221;default&#8221; global_colors_info=&#8221;{}&#8221;]<\/p>\n<p>\u00c1REA: <a href=\"https:\/\/www.idisantiago.es\/gl\/areas-de-investigacion\/a003-endocrinologia\/\">ENDOCRINOLOX\u00cdA<\/a><\/p>\n<p>[\/et_pb_text][\/et_pb_column][\/et_pb_row][et_pb_row column_structure=&#8221;2_3,1_3&#8243; _builder_version=&#8221;4.16&#8243; _module_preset=&#8221;default&#8221; width=&#8221;100%&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_column type=&#8221;2_3&#8243; _builder_version=&#8221;4.16&#8243; _module_preset=&#8221;default&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_image src=&#8221;https:\/\/www.idisantiago.es\/wp-content\/uploads\/2023\/04\/IMG-20230418-WA0000.jpg&#8221; title_text=&#8221;IMG-20230418-WA0000&#8243; disabled_on=&#8221;off|off|off&#8221; _builder_version=&#8221;4.19.4&#8243; _module_preset=&#8221;default&#8221; global_colors_info=&#8221;{}&#8221;][\/et_pb_image][et_pb_toggle title=&#8221;Obxectivos e li\u00f1as de investigaci\u00f3n&#8221; disabled_on=&#8221;off|off|off&#8221; admin_label=&#8221;Obxectivos e li\u00f1as de investigaci\u00f3n&#8221; _builder_version=&#8221;4.19.4&#8243; _module_preset=&#8221;default&#8221; body_font=&#8221;|300|||||||&#8221; global_colors_info=&#8221;{}&#8221;]<\/p>\n<h3>Obxectivos<\/h3>\n<p>O noso obxectivo \u00e9 atopar novas dianas terap\u00e9uticas para o tratamento da obesidade e as s\u00faas enfermidades asociadas estudando a regulaci\u00f3n de factores end\u00f3crinos ou sinais metab\u00f3licos sobre o balance enerx\u00e9tico e o metabolismo lip\u00eddico.<\/p>\n<h3>Li\u00f1as de investigaci\u00f3n<\/h3>\n<ul>\n<li>Busca novos obxectivos para o tratamento da obesidade: Pret\u00e9ndese iniciar unha nova li\u00f1a de investigaci\u00f3n traslacional desde unha perspectiva moi atractiva, pero ao mesmo tempo moi desco\u00f1ecida e innovadora, como \u00e9 a procura de v\u00ednculos moleculares entre as enfermidades neurodexenerativas e a obesidade.<\/li>\n<li>Busca novas dianas para o tratamento de enfermidades hep\u00e1ticas: A\u00ednda que o solicitante ten unha longa historia no campo da obesidade e do metabolismo, debido a que a incidencia de f\u00edgado graso non alcoh\u00f3lico\/esteatohepatite non alcoh\u00f3lica est\u00e1 aumentando basicamente debido ao gran aumento de pacientes con obesidade e diabetes tipo 2, o IP do grupo decidiu iniciar unha nova li\u00f1a de investigaci\u00f3n complementaria \u00e1 anterior.<\/li>\n<\/ul>\n<p>&nbsp;<\/p>\n<p>[\/et_pb_toggle][et_pb_toggle title=&#8221;Equipo investigador&#8221; admin_label=&#8221;Equipo investigador&#8221; _builder_version=&#8221;4.21.0&#8243; _module_preset=&#8221;default&#8221; body_font=&#8221;|300|||||||&#8221; hover_enabled=&#8221;0&#8243; global_colors_info=&#8221;{}&#8221; sticky_enabled=&#8221;0&#8243;]<\/p>\n<table style=\"width: 100%; border-collapse: collapse; border-style: hidden;\" border=\"0\">\n<tbody>\n<tr>\n<td style=\"width: 50%;\"><strong>L\u00edder<\/strong><br \/>Al-Massadi Iglesias, Omar<\/p>\n<p>&nbsp;<\/p>\n<p><strong>Membros<\/strong><br \/>Brea Garc\u00eda, Beatriz<br \/>Dobarro Rosales, Jaime<br \/>Fern\u00e1ndez Arias, Pablo<br \/>Fern\u00e1ndez Marcos, Adri\u00e1n \u00c1ngel<br \/>Prida Garc\u00eda, Eva<\/p>\n<\/td>\n<td style=\"width: 50%;\">\u00a0<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p>[\/et_pb_toggle][et_pb_toggle title=&#8221;Proxectos&#8221; disabled_on=&#8221;on|on|on&#8221; admin_label=&#8221;Proyectos (cambiar s\u00f3 codigo IDIS)&#8221; _builder_version=&#8221;4.16&#8243; _module_preset=&#8221;default&#8221; body_font=&#8221;|300|||||||&#8221; disabled=&#8221;on&#8221; locked=&#8221;off&#8221; global_colors_info=&#8221;{}&#8221;]<\/p>\n<strong>Asociaci\u00f3n entre los niveles de metilaci\u00f3n de los genes SOD1, C9orf72, TDP43 y FUS y el tratamiento cl\u00ednico nutricional en la evoluci\u00f3n de pacientes con ELA<\/strong><br \/>C\u00f3digo del proyecto: EPINUTRELA<br \/>Entidad financiadora: Fundaci\u00f3n Sociedad Espa\u00f1ola de Endocrinolog\u00eda y Nutrici\u00f3n<br \/>Duraci\u00f3n: 2020-2022<br \/>Cuant\u00eda: 6000 EUR<br \/>Investigador\/a principal: <a href=\"\"><\/a> ; Ana Cant\u00f3n Blanco<br \/><\/p>\n<p><strong>Axudas para a consolidaci\u00f3n e estructuraci\u00f3n de unidades de investigaci\u00f3n competitivas e outras acci\u00f3ns de fomento nos organismos p\u00fablicos de investigaci\u00f3n de Galicia e noutras entidades do sistema galego de I+D+i &#8211; Grupos de Potencial Crecemento<\/strong><br \/>C\u00f3digo del proyecto: IN607B2020<br \/>Entidad financiadora: Axencia Galega de Innovaci\u00f3n<br \/>Duraci\u00f3n: 2020-2022<br \/>Cuant\u00eda: 90000<br \/>Investigador\/a principal: <a href=\"\"><\/a> <br \/><\/p>\n<p><strong>Biomarcadores epigen\u00e9ticos y morfofuncionales de la respuesta a Tirzepatide en pacientes con Diabetes Mellitus tipo 2: hacia una medicina de precisi\u00f3n<\/strong><br \/>C\u00f3digo del proyecto: EPITIRZE-SED2024<br \/>Entidad financiadora: Sociedad Espa\u00f1ola de Diabetes<br \/>Duraci\u00f3n: 2024-2025<br \/>Cuant\u00eda: 20000 EUR<br \/>Investigador\/a principal: <a href=\"\"><\/a> Gemma Rodr\u00edguez-Carnero<br \/><\/p>\n<p><strong>Caracterizaci\u00f3n epigen\u00e9tica y morfofuncional del efecto de una intervenci\u00f3n nutricional en la enfermedad pulmonar obstructiva cr\u00f3nica (EPOC)<\/strong><br \/>C\u00f3digo del proyecto: EPIEPOC-SEEN2023<br \/>Entidad financiadora: Fundaci\u00f3n Sociedad Espa\u00f1ola de Endocrinolog\u00eda y Nutrici\u00f3n<br \/>Duraci\u00f3n: 2023-2025<br \/>Cuant\u00eda: 10000 EUR<br \/>Investigador\/a principal: <a href=\"\"><\/a> ; Gemma Rodr\u00edguez-Carnero<br \/><\/p>\n<p><strong>Characterization of breast cancer in obese women as a new molecular subtype: Relevance for the application of personalized therapy<\/strong><br \/>C\u00f3digo del proyecto: CP17\/00088<br \/>Entidad financiadora: Instituto de Salud Carlos III<br \/>Duraci\u00f3n: 2018-2021<br \/>Cuant\u00eda: 100000 EUR<br \/>Investigador\/a principal: <a href=\"\"><\/a> <br \/><\/p>\n<p><strong>Efecto epigen\u00e9tico de la intervenci\u00f3n nutricional sobre la sarcopenia y el pron\u00f3stico de la enfermedad obstructiva cr\u00f3nica (EPOC)<\/strong><br \/>C\u00f3digo del proyecto: EPIEPOC-SENPE2021<br \/>Entidad financiadora: Fundaci\u00f3n SENPE<br \/>Duraci\u00f3n: 2021-2022<br \/>Cuant\u00eda: 9412 EUR<br \/>Investigador\/a principal: <a href=\"\"><\/a> ; Gemma Rodr\u00edguez-Carnero<br \/><\/p>\n<p><strong>Epigenetics effect of nutritional intervention to improve cachexia in head and neck cancer patients<\/strong><br \/>C\u00f3digo del proyecto: Pfizer_78434893<br \/>Entidad financiadora: Pfizer Global Medical Grants<br \/>Duraci\u00f3n: 2023-2025<br \/>Cuant\u00eda: 220000 EUR<br \/>Investigador\/a principal: <a href=\"\"><\/a> <br \/><\/p>\n<p><strong>Evaluaci\u00f3n del efecto de la p\u00e9rdida de peso inducida por intervenci\u00f3n nutricional durante el tratamiento oncol\u00f3gico sobre las marcas epigen\u00e9ticas y el pron\u00f3stico de c\u00e1ncer de mama asociado a la obesidad<\/strong><br \/>C\u00f3digo del proyecto: PI20\/00650<br \/>Entidad financiadora: Instituto de Salud Carlos III<br \/>Duraci\u00f3n: 2021-2023<br \/>Cuant\u00eda: 222640 EUR<br \/>Investigador\/a principal: <a href=\"\"><\/a> <br \/><\/p>\n<p><strong>Medicina de precisi\u00f3n basada en marcadores epigen\u00e9ticos para la suplementaci\u00f3n nutricional del embarazo<\/strong><br \/>C\u00f3digo del proyecto: EPI-DMG-SGENM<br \/>Entidad financiadora: Fundaci\u00f3n de Endocrinolog\u00eda y Nutrici\u00f3n Gallega<br \/>Duraci\u00f3n: 2021-2022<br \/>Cuant\u00eda: 3000 EUR<br \/>Investigador\/a principal: <a href=\"\"><\/a> ; Gemma Rodr\u00edguez-Carnero<br \/><\/p>\n<p><strong>Microbiome and methylome relationship before and after a weight loss treatment in liquid biopsia from patients with obesity-related liver disease for the identification of liver risk biomarkers<\/strong><br \/>C\u00f3digo del proyecto: ONCOHEPATOBESITY- OBN18PI04\/2019<br \/>Entidad financiadora: Instituto de Salud Carlos III<br \/>Duraci\u00f3n: 2018-2019<br \/>Cuant\u00eda: 90000 EUR<br \/>Investigador\/a principal: <a href=\"\"><\/a> <br \/><\/p>\n<p>\n<p>[\/et_pb_toggle][et_pb_toggle title=&#8221;Publicaci\u00f3ns&#8221; disabled_on=&#8221;off|off|off&#8221; admin_label=&#8221;Publicaciones&#8221; _builder_version=&#8221;4.19.4&#8243; _module_preset=&#8221;default&#8221; body_font=&#8221;|300|||||||&#8221; global_colors_info=&#8221;{}&#8221;]<\/p>\n<ul>\n<li>Prida E, \u00c1lvarez-Delgado Sara, Pena-le\u00f3n V, P\u00e9rez-Lois R, Ferno J, Seoane LM, Qui\u00f1ones M, O Al Massadi.\u00a0<strong>Liver brain crosstalk: focus in FGF-21 a systematic review.<\/strong>\u00a0<em>Int. J. Mol. Sci.<\/em>\u00a02022, 23(21), 13318;\u00a0<span style=\"color: #808000;\"><a style=\"color: #808000;\" href=\"https:\/\/doi.org\/10.3390\/ijms232113318\"><strong>doi: 10.3390\/ijms232113318.<\/strong><\/a><\/span><\/li>\n<li>Pena-Leon V, Folgueira C, Barja-Fern\u00e1ndez S, P\u00e9rez-Lois R, Da Silva Lima N, Martin M, Heras V, Martinez-Martinez S, Valero P, Iglesias C, Duquenne M, Al-Massadi O, Beiroa D, Souto Y, Fidalgo M, Sowmyalakshmi R, Guallar D, Cunarro J, Castelao C, Senra A, Gonz\u00e1lez-Saenz P, V\u00e1zquez-Cobela R, Leis R, Sabio G, Mueller-Fielitz H, Schwaninger M, L\u00f3pez M, Tovar S, Casanueva FF, Valjent E, Di\u00e9guez C, Prevot V, Nogueiras R, Seoane LM.<strong>\u00a0Prolonged breastfeeding protects from obesity by hypothalamic action of hepatic FGF21<\/strong>. PMID: 35879461.\u00a0<em>Nat Metab<\/em>. 2022 Jul;4(7):901-917.\u00a0<span style=\"color: #808000;\"><a style=\"color: #808000;\" href=\"https:\/\/doi.org\/10.1038\/s42255-022-00602-z\"><strong>doi: 10.1038\/s42255-022-00602-z.<\/strong><\/a><\/span><\/li>\n<li>O Al-Massadi, Parini P, Ferno J, Luquet S Qui\u00f1ones M.\u00a0<strong>Metabolic Actions of the Growth Hormone-Insulin Growth Factor-1 axis and its Interaction with the Central Nervous System<\/strong>.\u00a0<em>Rev Endocr Metab Disord<\/em>. 2022 Oct;23(5):919-930.<span style=\"color: #808000;\">\u00a0<strong>doi<span class=\"identifier doi\"><span class=\"id-label\">:\u00a0<\/span><a class=\"id-link\" style=\"color: #808000;\" href=\"https:\/\/doi.org\/10.1007\/s11154-022-09732-x\" target=\"_blank\" rel=\"noopener\" data-ga-category=\"full_text\" data-ga-action=\"DOI\">10.1007\/s11154-022-09732-x.<\/a><\/span><\/strong><\/span><\/li>\n<li>Omar Al-Massadi, Carlos Dieguez, Marc Schneeberger, Miguel L\u00f3pez, Markus Schwaninger, Vincent Prevot, Ruben Nogueiras. <strong>Multifaceted actions of melanin-concentrating hormone on mammalian energy homeostasis.<\/strong>\u00a0<em>Nat Rev Endocrinol<\/em>. 2021 Dec;17(12):745-755.\u00a0<span style=\"color: #808000;\"><strong>doi<span class=\"identifier doi\"><span class=\"id-label\">:\u00a0<\/span><a class=\"id-link\" style=\"color: #808000;\" href=\"https:\/\/doi.org\/10.1038\/s41574-021-00559-1\" target=\"_blank\" rel=\"noopener\" data-ga-category=\"full_text\" data-ga-action=\"DOI\">10.1038\/s41574-021-00559-1.<\/a><\/span><\/strong><\/span><\/li>\n<li>Al-Massadi O*, Mastrolia V*, De Pins B, Girault JA.\u00a0<strong>Pyk2 in dorsal hippocampus plays a selective role in spatial memory and synaptic plasticity.<\/strong>\u00a0<em>Sci Rep.<\/em>\u00a02021 Aug 11;11(1):16357.\u00a0<span style=\"color: #808000;\"><strong><a style=\"color: #808000;\" href=\"https:\/\/doi.org\/10.1038\/s41598-021-95813-x\">doi: 10.1038\/s41598-021-95813-x.<\/a><\/strong><\/span><\/li>\n<li>Mar Qui\u00f1ones, Ren\u00e9 Hern\u00e1ndez-Bautista, Daniel Beiroa, Violeta Heras, Francisco L. Torres-Leal, Brian Y.H. Lam, Ana Senra, Johan Fern\u00f8 J, Alicia Garc\u00eda G\u00f3mez-Valad\u00e9s, Markus Schwaninger, Vincent Prevot, Giles Yeo, Marc Claret, Miguel L\u00f3pez, Carlos Di\u00e9guez C, Omar Al-Massadi, Ruben Nogueiras.\u00a0<strong>Sirt3 in POMC neurons controls energy balance in a sex- and diet- dependent manner<\/strong>. PMID: 33744652.\u00a0<em>Redox Biol<\/em>. 2021 Mar 13;41:101945.<span style=\"color: #808000;\">\u00a0<strong>doi<span class=\"identifier doi\"><span class=\"id-label\">:\u00a0<\/span><a class=\"id-link\" style=\"color: #808000;\" href=\"https:\/\/doi.org\/10.1016\/j.redox.2021.101945\" target=\"_blank\" rel=\"noopener\" data-ga-category=\"full_text\" data-ga-action=\"DOI\">10.1016\/j.redox.2021.101945.<\/a><\/span><\/strong><\/span><\/li>\n<li>Quinones M, Ferno J, Al-Massadi O.\u00a0<strong>Ghrelin and liver disease<\/strong>.\u00a0<em>Rev Endocr Metab Disord<\/em>. 2020 Mar;21(1):45-56.<span style=\"color: #808000;\">\u00a0<strong>doi<span class=\"identifier doi\"><span class=\"id-label\">:\u00a0<\/span><a class=\"id-link\" style=\"color: #808000;\" href=\"https:\/\/doi.org\/10.1007\/s11154-019-09528-6\" target=\"_blank\" rel=\"noopener\" data-ga-category=\"full_text\" data-ga-action=\"DOI\">10.1007\/s11154-019-09528-6.<\/a><\/span><\/strong><\/span><\/li>\n<\/ul>\n<p>[\/et_pb_toggle][et_pb_toggle title=&#8221;Web do grupo&#8221; disabled_on=&#8221;on|on|on&#8221; admin_label=&#8221;Web del grupo&#8221; _builder_version=&#8221;4.16&#8243; _module_preset=&#8221;default&#8221; body_font=&#8221;|300|||||||&#8221; disabled=&#8221;on&#8221; global_colors_info=&#8221;{}&#8221;]<\/p>\n<p>https:\/\/<\/p>\n<p>[\/et_pb_toggle][\/et_pb_column][et_pb_column type=&#8221;1_3&#8243; _builder_version=&#8221;4.16&#8243; _module_preset=&#8221;default&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_text admin_label=&#8221;Investigador\/a l\u00edder&#8221; _builder_version=&#8221;4.19.4&#8243; _module_preset=&#8221;default&#8221; text_text_color=&#8221;#FFFFFF&#8221; header_text_color=&#8221;#FFFFFF&#8221; header_2_text_align=&#8221;left&#8221; header_2_text_color=&#8221;#FFFFFF&#8221; background_color=&#8221;#10294c&#8221; custom_margin=&#8221;0px||||false|false&#8221; custom_padding=&#8221;6px||0px|6px|false|false&#8221; locked=&#8221;off&#8221; global_colors_info=&#8221;{}&#8221;]<\/p>\n<h2>Investigador l\u00edder<\/h2>\n<p>[\/et_pb_text][et_pb_text admin_label=&#8221;WP Team (cambiar s\u00f3 a ID pola do l\u00edder de equipo)&#8221; _builder_version=&#8221;4.19.4&#8243; _module_preset=&#8221;default&#8221; locked=&#8221;off&#8221; global_colors_info=&#8221;{}&#8221;]<\/p>\n<div class=\"sp-wp-team-pro-wrapper wp-team-pro-preloader\" >\n\n<div id=\"sptp-27485\" class=\"sp-team-pro sptp-section sptp-new_page pagination_normal sptp-even\" >\n\n\t<div class=\"sp-team-pro-page-loading-image\"><\/div>\n\t<div class=\"sptp-grid\">\n\t\t<div class=\"sptp-row  \">\n\t\t\t\t\t<div class=\"sp-team-pro-item sptp-col-lg-1 sptp-col-md-1 sptp-col-sm-1 sptp-col-xs-1\"\n\t\t\t data-member=\"27475\">\n\t\t\t\t<div class=\"sptp-member  border-bg-around-member sptp-square\">\n\t<a class=\"sptp-member-avatar \"  href=https:\/\/www.idisantiago.es\/gl\/team\/omar-al-massadi-iglesias\/ target=_blank >\n\t<div class=\"sptp-member-avatar-img-area\" data-id=\"27475\">\n\t\t<div class=\"sptp-member-avatar-img sptp-square sptp-icon-on-image none \">\n\t\t\t<div class=\"sptp-overflow-h\">\n\t\t\t\t\t\t\t\t\t<div class=\"sptp-icon text-center\">\n\t\t\t\t\t<i class=\"fa fa-plus\"><\/i>\t\t\t\t\t<\/div>\n\t\t\t\t\t\t\t\t<img loading=\"lazy\" decoding=\"async\" class=\"sptp_default_img\" srcset=\"https:\/\/www.idisantiago.es\/wp-content\/uploads\/2023\/04\/IMG-20230420-WA0000-1-320x320.jpg\" src=\"https:\/\/www.idisantiago.es\/wp-content\/uploads\/2023\/04\/IMG-20230420-WA0000-1-320x320.jpg\" alt=\"Omar Al-Massadi Iglesias\" width=\"320\" height=\"320\">\n\t\t\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t<\/div>\n<\/a>\n\t<div class=\"sptp-member-name \">\n\t\t<h2>\n\t\t\t\t\tOmar Al-Massadi Iglesias\t\t\t\t<\/h2>\n\t<\/div>\n<div class=\"sptp-member-email\">\n\n<i class=\"fa fa-envelope\"><\/i>\t<a href=\"#0\"  class=\"\">\n\t\t<span>omar.al-massadi.iglesias@sergas.es<\/span>\n\t<\/a>\n\t<\/div>\n<div class=\"sptp-member-website\">\n<i class=\"fa fa-globe\"><\/i>\t<a href=\"https:\/\/orcid.org\/0000-0003-0645-6159\"  class=\"\" target=\"_blank\">\n\t\t<span>https:\/\/orcid.org\/0000-0003-0645-6159<\/span>\n\t<\/a>\n\t<\/div>\n<div class=\"sptp-read-more-button\">\n\t<a class=\"sptp-member-read-more-button\" href=\"https:\/\/www.idisantiago.es\/gl\/team\/omar-al-massadi-iglesias\/\"> + INFO <\/a>\n<\/div>\n<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div> <!-- end row -->\n\t<\/div> <!-- end grid -->\n\t\t\t<\/div>\n<\/div>\n\n<p>[\/et_pb_text][\/et_pb_column][\/et_pb_row][\/et_pb_section]<\/p>\n","protected":false},"excerpt":{"rendered":"<p>\u00c1REA: ENDOCRINOLOX\u00cdAObxectivos O noso obxectivo \u00e9 atopar novas dianas terap\u00e9uticas para o tratamento da obesidade e as s\u00faas enfermidades asociadas estudando a regulaci\u00f3n de factores end\u00f3crinos ou sinais metab\u00f3licos sobre [&hellip;]<\/p>\n","protected":false},"author":14,"featured_media":10312,"comment_status":"closed","ping_status":"closed","template":"","meta":{"_et_pb_use_builder":"on","_et_pb_old_content":"","_et_gb_content_width":"","inline_featured_image":false,"footnotes":""},"project_category":[505],"project_tag":[],"class_list":["post-27539","project","type-project","status-publish","has-post-thumbnail","hentry","project_category-endocrinologia-gl"],"publishpress_future_workflow_manual_trigger":{"enabledWorkflows":[]},"_links":{"self":[{"href":"https:\/\/www.idisantiago.es\/gl\/wp-json\/wp\/v2\/project\/27539","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.idisantiago.es\/gl\/wp-json\/wp\/v2\/project"}],"about":[{"href":"https:\/\/www.idisantiago.es\/gl\/wp-json\/wp\/v2\/types\/project"}],"author":[{"embeddable":true,"href":"https:\/\/www.idisantiago.es\/gl\/wp-json\/wp\/v2\/users\/14"}],"replies":[{"embeddable":true,"href":"https:\/\/www.idisantiago.es\/gl\/wp-json\/wp\/v2\/comments?post=27539"}],"version-history":[{"count":11,"href":"https:\/\/www.idisantiago.es\/gl\/wp-json\/wp\/v2\/project\/27539\/revisions"}],"predecessor-version":[{"id":46775,"href":"https:\/\/www.idisantiago.es\/gl\/wp-json\/wp\/v2\/project\/27539\/revisions\/46775"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.idisantiago.es\/gl\/wp-json\/wp\/v2\/media\/10312"}],"wp:attachment":[{"href":"https:\/\/www.idisantiago.es\/gl\/wp-json\/wp\/v2\/media?parent=27539"}],"wp:term":[{"taxonomy":"project_category","embeddable":true,"href":"https:\/\/www.idisantiago.es\/gl\/wp-json\/wp\/v2\/project_category?post=27539"},{"taxonomy":"project_tag","embeddable":true,"href":"https:\/\/www.idisantiago.es\/gl\/wp-json\/wp\/v2\/project_tag?post=27539"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}